Australia's largest stock trading and investment forum Australia's #1 stock forum

IMM

Click for more information

0.00%

45.0¢ immutep limited

Ann: Immutep Completes Enrolment for TACTI-003 Phase IIb Trial, page-6

First 6 Last

Share
Profile

Follow
Joe007

2,497 Posts.

279

09/11/23

13:43

Post #: 70809893
Share

Originally posted by megamutts: ↑

Hey Green - I was also irritated about the delay, particularly when it looked like that the trial would be fully enrolled by mid-year. but it looks like that they increased the enrolment to 171 patients from the original 154 targeted. the announcement is good in that they allocated 33 patients with PD-L1 less than 1 to cohort B.

What is annoying is why didn't IMM tell shareholders that. A further expansion of the trial is obviously a good thing, with more data to help support approval (Marc has previously said that if the data is compelling IMM will go to the FDA to seek approval based on these results).

Expand

yes mega , wonder if the increase in the number of patients enrolled was done on the request of the FDA

IMM Price at posting: 29.0¢ Sentiment: Buy Disclosure: Held
9 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 12 more messages in this thread...

First 6 Last

Add IMM (ASX) to my watchlist

(20min delay)
Last 45.0¢		Change 0.000(0.00%)		Mkt cap ! $534.9M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
2	3373	46.0¢

Sellers (Offers)

Price($)	Vol.	No.
39.5¢	1562	1

View Market Depth

No.	Vol.	Price($)
2	3373	0.460
1	10989	0.455
1	7000	0.440
1	7000	0.435
3	9525	0.430

Price($)	Vol.	No.
0.395	1562	1
0.400	2712	1
0.410	10000	1
0.420	5250	2
0.430	50000	1

Last trade - 14.38pm 03/06/2024 (20 minute delay)

IMM (ASX) Chart

Day chart unavailable